Component: (Network and Table)
Network
00100 - Statement - BALANCE SHEETS
(http://www.celldextherapeutics.com/role/StatementBalanceSheets)
Table(Implied)
Slicers (applies to each fact value in each table cell)
Reporting Entity [Axis]0000744218 (http://www.sec.gov/CIK)
BALANCE SHEETSPeriod [Axis]
2016-12-31
2015-12-31
BALANCE SHEETS
 
 
ASSETS
 
 
Current Assets:
 
 
Cash and Cash Equivalents
42,461,000  
72,108,000  
Marketable Securities
147,315,000  
217,781,000  
Accounts and Other Receivables
1,784,000  
970,000  
Prepaid and Other Current Assets
4,009,000  
4,077,000  
Total Current Assets
195,569,000  
 
294,936,000  
 
Property and Equipment, Net
13,192,000  
11,461,000  
Intangible Assets, Net
81,487,000  
20,794,000  
Other Assets
2,134,000  
1,428,000  
Goodwill
90,976,000  
8,965,000  
Total Assets
383,358,000  
 
337,584,000  
 
LIABILITIES AND STOCKHOLDERS' EQUITY
 
 
Current Liabilities:
 
 
Accounts Payable
1,740,000  
1,506,000  
Accrued Expenses
28,657,000  
24,316,000  
Current Portion of Long-Term Liabilities
4,826,000  
4,418,000  
Total Current Liabilities
35,223,000  
 
30,240,000  
 
Other Long-Term Liabilities
82,704,000  
17,239,000  
Total Liabilities
117,927,000  
 
47,479,000  
 
Commitments and Contingent Liabilities (Notes 13 and 15)
xsi:nil  
xsi:nil  
Stockholders' Equity:
 
 
Convertible Preferred Stock, $.01 Par Value; 3,000,000 Shares Authorized; No Shares Issued and Outstanding at December 31, 2016 and 2015
xsi:nil  
xsi:nil  
Common Stock, $.001 Par Value; 297,000,000 Shares Authorized; 120,516,654 and 98,685,595 Shares Issued and Outstanding at December 31, 2016 and 2015, respectively
121,000  
99,000  
Additional Paid-In Capital
982,255,000  
878,655,000  
Accumulated Other Comprehensive Income
2,541,000  
2,307,000  
Accumulated Deficit
(719,486,000) 
(590,956,000) 
Total Stockholders' Equity
265,431,000  
 
290,105,000  
 
Total Liabilities and Stockholders' Equity
383,358,000  
 
337,584,000